Want to see JP:4028 full AI Analyst Report?
4028 Stock Chart & Stats
¥3215.00
-¥127.00(-4.20%)
At close: 4:00 PM EDT
¥3215.00
-¥127.00(-4.20%)
Day’s Range― - ―
52-Week Range¥2,328.00 - ¥4,035.00
Previous CloseN/A
Volume386.80K
Average Volume (3M)177.35K
Market Cap
¥106.84B
Enterprise Value¥146.33B
Total Cash (Recent Filing)¥29.74B
Total Debt (Recent Filing)¥67.01B
Price to Earnings (P/E)7.9
Beta1.17
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.24%
Share Statistics
EPS (TTM)337.42
Shares Outstanding40,383,945
10 Day Avg. Volume220,130
30 Day Avg. Volume177,350
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)0.82
Price to Sales (P/S)0.68
P/FCF Ratio19.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)248.25
Revenue Forecast (FY)¥151.60B
Bulls Say, Bears Say
Bulls Say
Profitability And Revenue GrowthThe company combines steady multi-year revenue growth with a substantial 2026 margin expansion, indicating stronger earnings capacity from its chemical operations. If maintained, improved profitability can support internal investment, strengthen resilience, and provide a more durable base for future earnings.
Improved Balance SheetLower debt-to-equity alongside significant equity growth indicates that the balance sheet has strengthened over the longer period shown. This gives the company greater financial flexibility to support operations and investment, although the improvement does not eliminate leverage-related constraints.
Operating Cash Flow RecoveryThe return to positive operating cash flow in the latest two years is an important improvement in the company’s ability to fund operations through internally generated cash. A sustained recovery would make profitability more useful financially and reduce reliance on external funding.
Bears Say
Low Free Cash Flow ConversionFree cash flow conversion remains weak relative to reported earnings, meaning a relatively small portion of net income became cash available for reinvestment, debt reduction, or shareholder returns. Unless conversion improves, reported profitability may overstate financial flexibility and constrain capital allocation.
Cyclical Earnings QualityThe uneven multi-year earnings pattern suggests that the company’s profitability is sensitive to operating conditions rather than consistently compounding. This cyclicality can make future earnings and cash generation less predictable, complicating investment planning and reducing confidence in peak-period margins.
Material Debt ExposureAlthough leverage improved by 2026, the company still carries substantial absolute debt and has recently experienced periods of rising leverage. That structure can limit financial flexibility during weaker operating conditions and leaves debt management an ongoing consideration for capital allocation.
ISHIHARA SANGYO KAISHA, LTD. News
4028 FAQ
What was ISHIHARA SANGYO KAISHA, LTD.’s price range in the past 12 months?
ISHIHARA SANGYO KAISHA, LTD. lowest stock price was ¥2328.00 and its highest was ¥4035.00 in the past 12 months.
What is ISHIHARA SANGYO KAISHA, LTD.’s market cap?
ISHIHARA SANGYO KAISHA, LTD.’s market cap is ¥106.84B.
When is ISHIHARA SANGYO KAISHA, LTD.’s upcoming earnings report date?
ISHIHARA SANGYO KAISHA, LTD.’s upcoming earnings report date is Nov 06, 2026 which is in 6 days.
How were ISHIHARA SANGYO KAISHA, LTD.’s earnings last quarter?
ISHIHARA SANGYO KAISHA, LTD. released its earnings results on Aug 07, 2026. The company reported ¥26.49 earnings per share for the quarter.
Is ISHIHARA SANGYO KAISHA, LTD. overvalued?
According to Wall Street analysts ISHIHARA SANGYO KAISHA, LTD.’s price is currently Overvalued.
Does ISHIHARA SANGYO KAISHA, LTD. pay dividends?
ISHIHARA SANGYO KAISHA, LTD. pays a Semiannually dividend of ¥80 which represents an annual dividend yield of 5.24%. See more information on ISHIHARA SANGYO KAISHA, LTD. dividends here
What is ISHIHARA SANGYO KAISHA, LTD.’s EPS estimate?
ISHIHARA SANGYO KAISHA, LTD.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ISHIHARA SANGYO KAISHA, LTD. have?
ISHIHARA SANGYO KAISHA, LTD. has 40,383,945 shares outstanding.
What happened to ISHIHARA SANGYO KAISHA, LTD.’s price movement after its last earnings report?
ISHIHARA SANGYO KAISHA, LTD. reported an EPS of ¥26.49 in its last earnings report. Following the earnings report the stock price went up 2.104%.
Which hedge fund is a major shareholder of ISHIHARA SANGYO KAISHA, LTD.?
Currently, no hedge funds are holding shares in JP:4028
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ISHIHARA SANGYO KAISHA, LTD.
Ishihara Sangyo Kaisha, Ltd. is a global producer and distributor of both organic and inorganic chemicals, with its operations spanning Japan, Asia, the United States, Europe, and other international markets. A key segment of its product line consists of TIPAQUE brand titanium dioxide (TiO2) offerings. These encompass white pigments, widely utilized in the production of items such as paints, inks, plastics, and paper, alongside yellow pigments. Additionally, the company provides an array of functional materials, including ultrafine TiO2, ultrafine ZnO, electro-conductive substances, photocatalytic TiO2, high-purity TiO2, titanium tetrachloride, TiO2 for catalytic applications, acicular TiO2, glass coatings, and battery components. Its broader chemical portfolio also features matting agents, heat-shielding substances, and various agrochemicals like herbicides, fungicides, insecticides, and nematicides. Furthermore, Ishihara Sangyo supplies animal healthcare products, pharmaceutical reagents, and CF3-Pyridine organic intermediates specifically for pharmaceutical research. The company, which maintains its corporate headquarters in Osaka, Japan, was established in 1920.
Technical Analysis
Kansai Paint Co
―
Nippon Paint Holdings Co
―
DIC
―
Dainichiseika Color & Chemicals Mfg.Co., Ltd.
―
Sakata Inx Corp.
―